by Marion Nestle

Currently browsing posts about: Infant-formula

Jun 8 2020

Coronavirus marketing ploy of the week: donating infant formula

Simón Barquera of the Mexican Institute for Public Health in Cuernavaca sent me this gem.
This gives me a chance to point out that Nestlé, the largest food company in the world, is not a relative, fortunately or unfortunately, depending on how you look at it.

The key phrases here:

“Together we can nourish our lives.”

“For each can of formula, Farmacias YZA, FEMSA [the Coca-Cola bottler in Mexico], and Nestlé will donate 3 more cans.”

“In tough times, we support those who need it most.”

Why is pushing infant formula a problem?  See tomorrow’s post.

Mar 16 2020

Industry funded study of the week: the benefits of infant formula

The study:  Influence of a Functional Nutrients-Enriched Infant Formula on Language Development in Healthy Children at Four Years Old.  Ana Nieto-Ruiz, et al.  Nutrients 202012(2), 535; https://doi.org/10.3390/nu12020535

Conclusion: “The functional compound-enriched infant formula seems to be associated with beneficial long-term effects in the development of child’s language at four years old in a similar way to breastfed infants.”

Funding: “This project has been funded by Ordesa Laboratories, S.L.” Ordesa Laboratories, you will not be surprised to know, makes infant formula products.

Comment:  Infant formula companies have a problem: the products are virtually identical in nutrient composition (they all have to meet the same nutritional standards), babies only need them for the first year at most, and the number of babies is finite.  From the formula industry’s perspective, the challenge is how to increase sales.  This study shows that formula works pretty much as well as breast milk, no surprise.
But it got press attention: “Nutrient-enriched infant formula appears beneficial for kid’s language development, study finds.”

Feb 26 2020

What’s up with infant formula?

DairyReporter.com has a Special Edition on infant feeding 

Infant formula companies have a problem: the products are virtually identical in nutrient composition (they all have to meet the same FDA standards), babies only need them for the first year, and the number of babies is finite.  From the formula industry’s perspective, the challenge is how to increase sales.  Here’s how this industry is managing this challenge.

Where next for infant nutrition?

In this special edition, we take a look at the infant formula sector, which far from being static is changing through novel ingredients, smart packaging, the explosion in plant-based products, and production of breast milk from cells.

Feb 19 2020

Formula companies push “toddler milk”

Formula companies must be desperate for sales.  They are spending four times what they used to on advertising of “toddler milk,” formula ostensibly aimed at children who no longer need infant formula and are perfectly capable of eating real food.

So says a new study in the journal Public Health Nutrition.  The study comes from the Rudd Center for Food Policy and Obesity, now at the University of Connecticut in Hartford, a group specializing in research to inform policy.

The report points out that increasing sales of toddler formula come at a time when pediatric authorities specifically recommend against feeding toddler milks to young children.

Why?  Because young kids do not need them and the milks contain unnecessary added sugars.

As the paper points out, “These findings also support the need to regulate marketing of toddler milks in countries that prohibit infant formula marketing to consumers.”

The advertising of toddler milks gets around those policies and should stop.  Right now.

Jul 11 2019

A roundup of articles on the infant formula industry

DairyReporter.com is another one of those industry newsletters I so enjoy reading.  This particular article is a roundup of articles on the infant formula industry.

Special Edition: Infant nutrition

The field of infant nutrition is a constantly evolving one, as new ingredients are constantly being added to provide greater benefits, and products are being developed to more closely approximate breast milk for those unable to breast feed. In this special edition, DairyReporter takes a look at some recent innovation in the infant nutrition space.

Breastfeeding, anyone?

 

Jul 16 2018

The Trump Administration’s support of infant formula v. breastfeeding

By this time, you have no doubt heard about the Trump Administration’s attempts to stop the World Health Organization from promoting breastfeeding.  Incredible but true.

Here is a brief timeline of how this story got out.

May 25   Lucy Sullivan, executive director o 1000 Days (the first 1000 days of life are critical to an infant’s survival) sent out a tweet warning of a battle brewing over breastfeeding at WHO’s World Health Assembly, where countries are negotiating a resolution on infant and young child feeding.

June 7   Amruta Byatnal writes about “A Moment of Reckoning for Nutrition Advocates at the WHA” [World Health Assembly: “Nutrition advocates have accused the U.S. of siding with private sector interests, sparking a controversy over what they assumed would be a routine effort to provide advice on breastfeeding and the use of breast milk substitutes.”

July 8  The New York Times takes the story national: “Opposition to Breast-Feeding Resolution by U.S. Stuns World Health Officials.”  The Guardian also publishes an account.   These make it clear that the Trump Administration threatened Ecuador to drop its support of breastfeeding.  As the Times put it,

The Americans were blunt: If Ecuador refused to drop the resolution, Washington would unleash punishing trade measures and withdraw crucial military aid. The Ecuadorean government quickly acquiesced….The confrontation was the latest example of the Trump administration siding with corporate interests on numerous public health and environmental issues.

Ironically, Russia stepped in and introduced the measure, which passed despite US attempts to block it.

July 9  President Trump sends out a tweet:

July 9  Alex Azar, Secretary of Health and Human Services, also sends out a tweet, supporting the President: “America has a long history of supporting mothers and breastfeeding around the world and is the largest bilateral donor of such foreign assistance programs. Those unable to breastfeed shouldn’t be stigmatized; they should be equally supported with info and access to alternatives.”

July 9  The New York Times publishes an editorial: “Why Breast-Feeding Scares Donald Trump.”  Its answer: “It comes down to public health abroad could hurt American companies’ profits.”

What this is about

Infant formula works for babies, but breastfeeding is demonstrably better.  This is especially true for women who cannot afford formula, do not have clean water to dilute the powder properly, or lack refrigeration to store formula properly.

But breastfeeding has a serious political problem: it does not make money for formula companies.  As I explained in Waht to Eat:

Infant formulas cause controversy and are endlessly contentious for three important reasons.  Formulas are (1) largely unnecessary (most mothers can breast feed their infants), (2) not as perfect as breast milk for feeding babies, and (3) more expensive than breast feeding.  Breast milk is nutritionally superior to formula, but from a marketing standpoint it has one serious disadvantage: it is free.   Beyond one-time purchases of breast pumps, storage bottles, or special clothing, nobody makes money from it.

Formula companies are happy to pay lip service to “breast is best,” as long as policies do not promote breastfeeding over formula.

This is not the first time the US has taken this position.  In 1981, when the United Nations developed the International Code of Marketing of Breast-Milk Substitutes, all of its member countries agreed to abide by the Code except for the United States and South Africa.  Eventually, South Africa signed on.  The U.S. was the last hold out and did not agree to abide by the Code until 1994.  Why not?  Because the Code could set a precedent that might adversely affect U.S. corporations.

The Washington Post (“US efforts”) and The Atlantic (“epic battle”) review this history.

The formula industry’s problem

As I also explained in What to Eat, only about 4 million babies are born in the US each year, meaning that the formula market is limited and static.  That is why formula companies work so hard to convince mothers that breastfeeding is too difficult, unsanitary, inefficient, and ineffective to continue, and that they would be better off switching to formulas and staying on formulas long past the time when babies should be eating solid foods.

The reactions

My favorites are from

Add this to the growing list of ways the Trump Administration favors corporate interests over public health. Alas.

Additions

Maplight reports:

Three of the largest infant formula companies — U.S.-based Abbott Laboratories, Swiss-based Nestle, and U.K.-based Reckitt Benckiser — have spent $60.7 million lobbying U.S. lawmakers and officials during the last decade….While the New York Times reported that the formula manufacturers didn’t play a visible role in the debate over the WHO resolution, lobbying records show they have a significant Capitol Hill presence that often extends beyond infant nutrition.

Stephen Colbert’s take

 

Nov 4 2016

Weekend reading: Rudd Center report on baby food marketing

The Rudd Center for Food Policy & Obesity at the Univeristy of Connecticut  produces terrific reports.  The latest is Baby Food FACTS: Nutrition and marketing of baby and toddler foods and drinks:

 

Infant formula companies have a marketing problem: breast milk is a better option, all formulas have the same nutrient composition by FDA regulation, and babies only need to use formula for a few months.

Baby food companies also have a marketing problem: babies can eat table foods (suitably ground or cut) and don’t really need the stuff in jars (convenient thought they may be).

The Rudd Center report takes a good hard look at the

  • Contents of food and drink products marketed to parents for their babies and toddlers (up to age 3)
  • The marketing messages used to promote these products
  • Degree to which marketing messages correspond with expert advice on feeding young children

The findings: The nutritional quality is pretty much as advertised but nearly 60 percent of advertising dollars go for products that are not recommended for young children such as sugar-sweetened toddler milk, nutritionally poor snack food, and Pediasure, a high-calorie liquid nutrition supplement.

Here’s the full report 

And here’s a summary

Oct 25 2016

Comments wanted: FDA guidance on structure/function claims for infant formula. Deadline: November 8

The FDA wants to tighten up the rules for labels and advertising of “structure/function” claims on infant formulas.  It has proposed “guidance” and asks for comments on it.

This is a good proposal and needs all the support it can get.

Background

“Structure/function” claims were allowed by the Dietary Supplement Health and Education Act of 1994.  These are pseudo health claims that are really about marketing, not health.  Example: this brand of infant formula “supports digestion.”

All infant formulas must meet FDA nutritional requirements and there is no meaningful difference in any of them.  Structure/function claims market one brand over another.  Worse, they make infant formulas seem better than breast milk and help to discourage women from breastfeeding.

In September, the FDA announced that it was proposing draft guidance for industry, entitled “Substantiation for Structure/Function Claims Made in Infant Formula Labels and Labeling.”  This says that the infant formula industry must actually produce evidence that the claims do what they say.  Formula makers must substantiate structure/function claims with “competent and reliable evidence,” preferably from clinical research.

Infant formula makers would much rather not bother.

This proposal deserves enthusiastic support.  If you agree with it, please write the FDA and say so.

ChangeLab Solutions has filed a position paper on this topic with the FDA—excellent background reading.

It also has developed a template letter, which you can adapt and send.

But even a shorter statement that you think structure/function claims should not be used to market infant formulas without real science behind them would help.

Here’s the quick one I sent in.  Feel free to copy.  But individual letters carry more weight.

How to do this?

  • Go to the FDA docket website: look for ID: FDA-2016-D-2241.
  • Go to the first of the two FDA documents listed there.
  • Click on “Comment Now!”
  • Fill in the Comment box by saying you are commenting on FDA-2016-D-2241.
  • Upload your letter
  • Following the instructions for the required items (the others are voluntary)

The FDA documents